Three considerations before advising 5-alpha-reductase inhibitors for chemoprevention.
Walsh
Patrick C
PC
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008495:Medical Oncology; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D012955:Societies, Medical; D014481:United States
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors